The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy
Clinical trial NCT03601871 · UNKNOWN
Trial details
- NCT number
- NCT03601871
- Sponsor
- Yunpeng Liu
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-12
- Primary completion
- 2020-06-30
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.